The Nation - News from Sept. 9, 1986
- Share via
A public health advocacy group asked the Food and Drug Administration to order warning labels for a popular arthritis remedy, saying that the drug can be dangerous. The Public Citizen Health Research Group said clinical studies in Canada have shown that elderly patients taking Feldene attain a higher level of the drug in their blood than younger patients on the same dosage, and that this can cause gastrointestinal bleeding.
Sign up for Essential California
The most important California stories and recommendations in your inbox every morning.
You may occasionally receive promotional content from the Los Angeles Times.
